163 related articles for article (PubMed ID: 31126875)
1. Interleukin-34 as a promising clinical biomarker and therapeutic target for inflammatory arthritis.
Udomsinprasert W; Jittikoon J; Honsawek S
Cytokine Growth Factor Rev; 2019 Jun; 47():43-53. PubMed ID: 31126875
[TBL] [Abstract][Full Text] [Related]
2. Th22 Cells Promote Osteoclast Differentiation
Miyazaki Y; Nakayamada S; Kubo S; Nakano K; Iwata S; Miyagawa I; Ma X; Trimova G; Sakata K; Tanaka Y
Front Immunol; 2018; 9():2901. PubMed ID: 30619268
[TBL] [Abstract][Full Text] [Related]
3. Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
Talabot-Ayer D; McKee T; Gindre P; Bas S; Baeten DL; Gabay C; Palmer G
Joint Bone Spine; 2012 Jan; 79(1):32-7. PubMed ID: 21441054
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Interleukin-34 as a Novel Biomarker for Severity of Knee Osteoarthritis.
Udomsinprasert W; Panon K; Preechanukul S; Jittikoon J; Jinawath A; Honsawek S
Cartilage; 2021 Dec; 13(2_suppl):1174S-1184S. PubMed ID: 33550830
[TBL] [Abstract][Full Text] [Related]
5. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
7. IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis.
Moon YM; Yoon BY; Her YM; Oh HJ; Lee JS; Kim KW; Lee SY; Woo YJ; Park KS; Park SH; Kim HY; Cho ML
Arthritis Res Ther; 2012 Nov; 14(6):R246. PubMed ID: 23148681
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis.
Wang F; Xu L; Feng X; Guo D; Tan W; Zhang M
Arthritis Res Ther; 2012 Oct; 14(5):R228. PubMed ID: 23078630
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis.
Filková M; Vernerová Z; Hulejová H; Prajzlerová K; Veigl D; Pavelka K; Vencovský J; Šenolt L
Cytokine; 2015 May; 73(1):36-43. PubMed ID: 25697137
[TBL] [Abstract][Full Text] [Related]
12. Synoviocytes-derived Interleukin 35 Potentiates B Cell Response in Patients with Osteoarthritis and Rheumatoid Arthritis.
Kam NW; Liu D; Cai Z; Mak WY; Wong CK; Chiu KH; Wong KY; Tsang WL; Tam LS
J Rheumatol; 2018 Apr; 45(4):563-573. PubMed ID: 29247146
[TBL] [Abstract][Full Text] [Related]
13. Functions of interleukin-34 and its emerging association with rheumatoid arthritis.
Zhou RP; Wu XS; Xie YY; Dai BB; Hu W; Ge JF; Chen FH
Immunology; 2016 Dec; 149(4):362-373. PubMed ID: 27550090
[TBL] [Abstract][Full Text] [Related]
14. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway.
Min HK; Won JY; Kim BM; Lee KA; Lee SJ; Lee SH; Kim HR; Kim KW
Arthritis Res Ther; 2020 Sep; 22(1):222. PubMed ID: 32972460
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis.
Moon SJ; Hong YS; Ju JH; Kwok SK; Park SH; Min JK
J Rheumatol; 2013 Nov; 40(11):1842-9. PubMed ID: 23996288
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis.
Jüngel A; Distler JH; Kurowska-Stolarska M; Seemayer CA; Seibl R; Forster A; Michel BA; Gay RE; Emmrich F; Gay S; Distler O
Arthritis Rheum; 2004 May; 50(5):1468-76. PubMed ID: 15146416
[TBL] [Abstract][Full Text] [Related]
19. Multifaceted role of IL-21 in rheumatoid arthritis: Current understanding and future perspectives.
Dinesh P; Rasool M
J Cell Physiol; 2018 May; 233(5):3918-3928. PubMed ID: 28833093
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts.
Mun SH; Kim JW; Nah SS; Ko NY; Lee JH; Kim JD; Kim DK; Kim HS; Choi JD; Kim SH; Lee CK; Park SH; Kim BK; Kim HS; Kim YM; Choi WS
Arthritis Rheum; 2009 Mar; 60(3):678-85. PubMed ID: 19248119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
